Request Your Free White Paper Now:

"Real-world data: The new growth guide for biotech and pharma in 2023"

As the field of real-world data and evidence is constantly evolving, it can be hard to keep-up with best practices. Do you know the definitive characteristics of a high-quality dataset? What questions to ask if you decide to outsource your research to consultants? Here’s everything you need to know in one, must-have guide.

As you work on a successful path for your drug development and market access, you will encounter needs for robust real-world evidence (RWE) and high-quality real-world data (RWD). While you may consider many types of research studies, this guide focuses primarily on the most rigorous use cases with Health Economics & Outcomes Research, epidemiology studies, and regulatory approvals.

This whitepaper answers the following frequently asked questions:

• What makes a database a research-grade database?
• How can I enrich my data?
• How can I empower my research teams?
• What should I consider when outsourcing the generation of RWE?

Offered Free by: MarketScan by Merative
See All Resources from: MarketScan by Merative